Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Clinical Pharmacology and Therapeutics
|
December 21, 2006
ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment
Séverine Crettol, Jean-Jacques Déglon, Jacques Besson, et al.
Addictive Behaviors
|
September 3, 2005
Prevalence of substance use in a Swiss psychiatric hospital: interview reports and urine screening
Charles Bonsack, Didier Camus, Nadine Kaufmann, et al.
Revue Medicale Suisse
|
July 14, 2017
[Addictions]
Jacques Besson, Jeremy Grivel, Alexander Tomei, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 9, 2008
Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment
Séverine Crettol, Jacques Besson, Marina Croquette-Krokar, et al.
Journal of the Mechanical Behavior of Biomedical Materials
|
June 22, 2023
Strength and ductility loss of Magnesium-Gadolinium due to corrosion in physiological environment: Experiments and modeling
Dirk Steglich, Jacques Besson, Inken Reinke, et al.
Clinical Pharmacology and Therapeutics
|
December 13, 2005
Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment
Séverine Crettol, Jean-Jacques Déglon, Jacques Besson, et al.
Revue Medicale Suisse
|
March 4, 2010
[Addiction]
Jacques Besson, Charles Bonsack, Carina Ferrari, et al.
European Journal of Clinical Pharmacology
|
July 30, 2009
Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: a transnational study
Richard Hallinan, Séverine Crettol, Kingsley Agho, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Clinical Pharmacology and Therapeutics
|
December 21, 2006
ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment
Séverine Crettol, Jean-Jacques Déglon, Jacques Besson, et al.
Addictive Behaviors
|
September 3, 2005
Prevalence of substance use in a Swiss psychiatric hospital: interview reports and urine screening
Charles Bonsack, Didier Camus, Nadine Kaufmann, et al.
Revue Medicale Suisse
|
July 14, 2017
[Addictions]
Jacques Besson, Jeremy Grivel, Alexander Tomei, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 9, 2008
Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment
Séverine Crettol, Jacques Besson, Marina Croquette-Krokar, et al.
Journal of the Mechanical Behavior of Biomedical Materials
|
June 22, 2023
Strength and ductility loss of Magnesium-Gadolinium due to corrosion in physiological environment: Experiments and modeling
Dirk Steglich, Jacques Besson, Inken Reinke, et al.
Clinical Pharmacology and Therapeutics
|
December 13, 2005
Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment
Séverine Crettol, Jean-Jacques Déglon, Jacques Besson, et al.
Revue Medicale Suisse
|
March 4, 2010
[Addiction]
Jacques Besson, Charles Bonsack, Carina Ferrari, et al.
European Journal of Clinical Pharmacology
|
July 30, 2009
Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: a transnational study
Richard Hallinan, Séverine Crettol, Kingsley Agho, et al.
Page
of 4